Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday

Ginkgo Bioworks (NYSE:DNA) is expected to release its earnings data after the market closes on Thursday, March 6th. Analysts expect Ginkgo Bioworks to post earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Ginkgo Bioworks Stock Up 1.4 %

Shares of NYSE DNA opened at $8.13 on Wednesday. Ginkgo Bioworks has a twelve month low of $5.26 and a twelve month high of $51.20. The firm has a market cap of $467.02 million, a P/E ratio of -0.62 and a beta of 1.16. The company has a 50 day moving average of $11.46 and a 200 day moving average of $9.43.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.